Error! You must javascript enabled to use this form. Please enable Javascript in your browser. ChroMedX REPORTS on HEMOPALM DEVELOPMENT ChroMedX Corp. (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report on the Company's HemoPalm development program. View full press release Your Name: Your Email: Subject: Question: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send